Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L7 pseudogene 7 (RPL7P7) is a processed pseudogene found in the human genome. It is derived from the RPL7 gene, which encodes the 60S ribosomal protein L7, a component of the large ribosomal subunit involved in protein synthesis. As a pseudogene, RPL7P7 does not encode a functional protein product and is generally considered non-coding and non-functional. Such ribosomal protein pseudogenes are common in the genome and arise mainly through retrotransposition events; they generally have no biological function, no direct role in disease, and are not considered therapeutic targets. RPL7P7 is distinct from the functional RPL7 gene, which encodes a protein participating in translation as part of the ribosome. Like other pseudogenes, RPL7P7 is a genomic relic, not expressed as a functional protein. There are no known drugs, disease associations, or mechanisms of action connected to this pseudogene.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7 pseudogene 7 (RPL7P7).